No abstract

No abstract

No abstract

Various recently reported mutant variants, candidate and urgently approved current vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many current situations with severe neurological damage and symptoms as well as respiratory tract disorders have begun to be reported. In particular, drug, vaccine, and neutralizing monoclonal antibodies (mAbs) have been developed and are currently being evaluated in clinical trials. Here, we review lessons learned from the use of novel mutant variants of the COVID-19 virus, immunization, new drug solutions, and antibody therapies for infections. Next, we focus on the B 1.1.7, B 1.351, P.1, and B.1.617 lineages or variants of concern that have been reported worldwide, the new manifestations of neurological manifestations, the current therapeutic drug targets for its treatment, vaccine candidates and their efficacy, implantation of convalescent plasma, and neutralization of mAbs. We review specific clinical questions, including many emerging neurological effects and respiratory tract injuries, as well as new potential biomarkers, new studies in addition to known therapeutics, and chronic diseases of vaccines that have received immediate approval. To answer these questions, further understanding of the burden kinetics of COVID-19 and its correlation with neurological clinical outcomes, endogenous antibody responses to vaccines, pharmacokinetics of neutralizing mAbs, and action against emerging viral mutant variants is needed.

Backround: There is a positive relationship between night eating syndrome (NES) and sleep quality. However, it is not known how this situation changes among students during the COVID-19 pandemic. Aims and Objectives: This study aimed to reveal the relationship between anthropometric measurements, NES, and sleep quality in university students during the COVID-19 pandemic. Materials and Methods: Data were obtained through an online survey from March to June 2020 during pandemic in Turkey from university students (n = 100). They completed an online Pittsburgh Sleep Quality Index and Night Eating Questionnaire, also anthropometric measurements were taken. Results: University students had sleep disturbance. The sleep disturbance had an effect on NES (P < 0.001, rho = 0.386). A positive relation was found between sleeping pill use and NES (Z = −2.218, P = 0.027) and appetizing drugs and sleep (Z = −2.410, P = 0.016). Conlusion: The occurrence of sleep disturbances in students may increase the incidence of NES during COVID-19 pandemic. This study achieved a short-term result in a limited sample, and we suggest conducting large-scale studies on student health. University students should be considered and public health policies should be implemented in terms of eating disorders and sleep quality.